Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions (pH, temperature, timing). Reading the colour visually introduces subjectivity.
What I would want from a home test that does not exist yet posts 31–51
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.
Worth separating two things that post #28 runs together.
Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide and other structurally similar compounds. The test result conflates them.
What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds (semaglutide versus totally unrelated compound). What you cannot use them for: precise purity assessment or verification that the identity is correct.
Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative work.
Collapsed as off-topic by two members at trust level 3 or above
post #34 answers the question as asked. The question underneath it is different.
Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are less common than antibody-based tests.
On post #32 — agreed on the reasoning, with one qualification.
False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not guarantee presence. The predictive value depends on prevalence.
Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not nucleic-acid detection.
post #38 is right about the mechanism and I think understates the practical bit.
For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Worth separating two things that post #37 runs together.
Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.
What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It can distinguish "peptide present" from "nothing present" but generally cannot distinguish the intended peptide from a closely related one.
Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough category, not a quantitative number.
Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative work.
Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are less common than antibody-based tests.
I disagree with the reply above, and I think the disagreement is substantive rather than terminological.
The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.
Picking up post #45: that is the part I would want checked first.
What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It can distinguish "peptide present" from "nothing present" but generally cannot distinguish the intended peptide from a closely related one.
Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not nucleic-acid detection.
post #49 is right about the mechanism and I think understates the practical bit.
Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough category, not a quantitative number.
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Reflectance and photometric devices: precision in practice — a second dataset
Reflectance and photometric devices: precision in practice — a second dataset — setting out what I have, and where I think it stops being reliable. I would like to understand what this number means before I…
|
+75 | 82 | 17k | 12h |
|
Coming back to: Why quantitation is the hard part, not detection
Why quantitation is the hard part, not detection — that is the question, and I have not found it answered plainly anywhere I have looked. Posting the method first, because I know what the first three replies…
|
+86 | 92 | 54k | 8mo |
|
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem
On the subject in the title: Lateral-flow and colorimetric approaches: the specificity problem Working notes rather than a conclusion. I would like to understand what this number means before I repeat it…
|
+77 | 89 | 16k | 9h |
|
Why quantitation is the hard part, not detection
Why quantitation is the hard part, not detection I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the method first, because I know what the first three replies…
|
+11 | 15 | 27k | 12mo |
|
Reading a home test result without over-claiming
Reading a home test result without over-claiming — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I would like it checked. retatrutide has a…
|
+124 | 137 | 19k | 7h |
Related topics — sharing the tags ELISA, documentation quality, LOD & LOQ
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
LOD and LOQ: definitions people get wrong
LOD and LOQ: definitions people get wrong — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a certificate in front of me that…
|
2 | 43k | 8mo | |
|
An inter-laboratory comparison on one lot, tabulated — what changed since
An inter-laboratory comparison on one lot, tabulated — what changed since — setting out what I have, and where I think it stops being reliable. I would like to understand what this number means before I…
|
+24 | 28 | 3.3k | 7mo |
|
Follow-up: Why this community will not facilitate a group purchase
Why this community will not facilitate a group purchase I have a specific reason for asking rather than idle curiosity, and the context is below. A logistics question, since the answers here are usually…
|
2 | 19k | 18mo | |
|
Second pass at: A payment that went through twice: how it was resolved
On the subject in the title: Second pass at: A payment that went through twice: how it was resolved Working notes rather than a conclusion. A logistics question, since the answers here are usually better than…
|
2 | 1.1k | 14mo | |
|
Revisiting: Spike-and-recover accuracy for a peptide assay
Revisiting: Spike-and-recover accuracy for a peptide assay — setting out what I have, and where I think it stops being reliable. I would like to understand what this number means before I repeat it anywhere.…
|
2 | 6.8k | 21h |